Related Experiment Video

Updated: Aug 21, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

A novel site of AKT-mediated phosphorylation in the human MDM2 onco-protein

Diane Milne1, Petros Kampanis, Samantha Nicol

  • 1Molecular Signaling Group, Biomedical Research Centre, University of Dundee, Dundee DD1 9SY, UK.

FEBS Letters
|November 6, 2004
PubMed

Insights

Researchers identified two key phosphorylation sites, Ser-166 and Ser-188, on MDM2 (mouse double minute 2 homolog) by the AKT kinase. These findings clarify how AKT regulates MDM2

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • MDM2 (mouse double minute 2 homolog) is an E3 ubiquitin ligase crucial for degrading the p53 tumor suppressor.
  • The protein kinase AKT is known to phosphorylate MDM2, influencing its function in response to cellular survival signals.
  • Previous research had uncertainty regarding the specific sites on MDM2 targeted by AKT phosphorylation.

Purpose of the Study:

  • To precisely identify the serine residues on MDM2 phosphorylated by AKT.
  • To determine the physiological relevance of these phosphorylation events in cultured cells.

Main Methods:

  • In vitro kinase assays using AKT and MDM2.
  • Analysis of MDM2 phosphorylation sites.
  • Cellular studies to confirm phosphorylation in a physiological context.

Main Results:

  • Identified Ser-166 as a site of MDM2 phosphorylation by AKT.
  • Identified Ser-188 as a novel and major site of MDM2 phosphorylation by AKT in vitro.
  • Confirmed phosphorylation of both Ser-166 and Ser-188 in MDM2 within cultured cells.

Conclusions:

  • Ser-166 and the novel site Ser-188 are key targets for AKT-mediated phosphorylation of MDM2.
  • These findings clarify the mechanism by which AKT signaling regulates MDM2 activity and p53 stability.
  • Understanding these phosphorylation sites is critical for comprehending cancer cell survival pathways.

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.